Home / Products / L-Fucose
CAS 2438-80-4 Rare Deoxy Sugar Rare Deoxy Sugar High Purity

L-Fucose

IUPAC: 6-Deoxy-L-galactopyranose View on PubChem
CAS NUMBER
2438-80-4
MOL. FORMULA
C6H12O5
MOL. WEIGHT
164.16 g/mol
Scientific Overview

The methyl group at the C6 position (replacing the typical hydroxyl) gives L-fucose greater hydrophobicity than galactose, contributing to its distinct role in cell-surface recognition processes, including blood group antigen expression, Lewis antigen formation, and selectin-mediated leukocyte adhesion. Its presence on N- and O-linked glycans makes it a critical target in glycobiology research, biopharmaceutical glycoengineering (notably in antibody afucosylation strategies to enhance ADCC), and infant nutrition (as a component of HMOs).

L-Fucose (6-deoxy-L-galactose) is a naturally occurring deoxy hexose sugar and a key structural component of glycoproteins, glycolipids, and human milk oligosaccharides (HMOs). It is the only L-configured sugar commonly utilized by mammals, distinguishing it from most other biologically relevant monosaccharides.

Full Technical Data
Chemical Name L-Fucose (6-Deoxy-L-galactose)
CAS Number 2438-80-4
IUPAC Name 6-Deoxy-L-galactopyranose
Molecular Formula C6H12O5
Molecular Weight 164.16 g/mol g/mol
Reaction Scheme
Fucoidan (Brown Algal Polysaccharide)
NA
NA
L-Fucose
NA
Commercial Applications

Biopharmaceutical Glycoengineering

Used in monoclonal antibody research to study fucosylation's impact on ADCC activity and therapeutic efficacy.

Infant Nutrition / HMO Research

Structural component of fucosylated human milk oligosaccharides used in infant formula development.

Cosmetic & Dermatological Formulations

Applied in skincare products for its role in cell signaling and skin barrier-related research.

Glycobiology & Diagnostic Research

Substrate for studying fucosidases, fucosyltransferases, and Lewis/blood group antigen biology.

Market Therapeutic Focus
RARE DEOXY SUGAR PHARMACEUTICAL MANUFACTURING MONOCLONAL ANTIBODY GLYCOENGINEERING INFANT NUTRITION / HMOS COSMECEUTICALS CRO/CDMO
Scientific Literature

Fucosylation in Human Milk Oligosaccharides

Authors: Bode, L.

Glycobiology

The Role of Core Fucosylation in Antibody Effector Function

Authors: Shields, R.L. et al.

J. Biol. Chem.

Fucose: Biosynthesis and Biological Function in Mammals

Authors: Becker, D.J.; Lowe, J.B.

Glycobiology

Peer Queries & FAQs
Why is L-fucose important in antibody engineering?
Removing core fucose from IgG antibodies (afucosylation) significantly enhances antibody-dependent cellular cytotoxicity (ADCC), making fucosylation control a key lever in therapeutic antibody design.
What natural sources are used to obtain L-fucose?
Primarily fucoidan from brown seaweed, as well as plant polysaccharides like tragacanth gum and select fruits/vegetables.
Is L-fucose used in infant formula?
Yes, as a structural component of fucosylated HMOs, which are increasingly incorporated into infant nutrition products to mimic breast milk composition.
What is the recommended storage condition?
Store in a tightly sealed container at room temperature (10--25°C), protected from moisture due to its hygroscopic nature.

Need a Custom Derivative or Labeled Analog?

Our R&D centers specialize in the design and process development of complex heterocyclic and chiral molecules — mg to kg scale.